Blastic plasmacytoid dendritic cell neoplasm

Dr Henry Knipe and Dr Yuranga Weerakkody et al.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy. It was previously termed as blastic natural-killer lymphoma or agranular CD4+ natural killer cell leukemia.

It only represent a wel small propotion (around 0.44%) of all haematological malignancies 4. There may be a slight male predilection.

It often presents in the skin. Clinical course can be aggressive in adults and apparently milder in children. Some patient may have a leukaemic presenation 5.

Histologically, the tumour cells may be either blastoid or pleomorphic. The express several markers of plasmacytoid dendritic cells which include

  • CD123
  • TCL1
  • BDCA2
  • CD2AP

Has been described as interstitial opacities with a ground glass and reticular opacities 4.

Lymphadenopathy and hepatosplenomegaly may be present.

Skin lesions and lymph node metastases may appear hypermetabolic on F18-FDG PET imaging. Positive bone marrow involvement, however, may not be always evident on F18-FDG PET 4.

Chemotherapy is the preferred treatment, along with allogeneic stem cell transplantation. Patients usually have a poor outcome with a median survival reported around 12-14 months. Advanced stage and older age may imply poorer prognosis 4.

Share article

Article information

rID: 55923
Synonyms or Alternate Spellings:
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
  • BPDCN

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.